Recombinant Follicle-stimulating Hormone in Treatment for Infertility
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-03-04
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Bharat Serums and Vaccines Limited
- Target Recruit Count
- 250
- Registration Number
- NCT05266924
- Locations
- 🇮🇳
Om Research Center Om Surgical Center and Maternity Home, Varanasi, Uttar Pradesh, India
Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-06-04
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Bharat Serums and Vaccines Limited
- Target Recruit Count
- 155
- Registration Number
- NCT04914195
- Locations
- 🇮🇳
Government Med ical College & Superspeciality Hospital Nagpur, Nagpur, Maharashtra, India
🇮🇳MV hospital and Research Center, Lucknow, Uttar Pradesh, India
Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2022-10-14
- Lead Sponsor
- Bharat Serums and Vaccines Limited
- Target Recruit Count
- 7
- Registration Number
- NCT04834908
- Locations
- 🇮🇳
Jehangir Hospital, Pune, Maharashtra, India
To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-04-07
- Last Posted Date
- 2011-06-02
- Lead Sponsor
- Bharat Serums and Vaccines Limited
- Target Recruit Count
- 500
- Registration Number
- NCT00876824
© Copyright 2024. All Rights Reserved by MedPath